MedPath

河北龙海药业有限公司

Ownership
-
Established
1998-07-27
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

33

NMPA:33

Drug Approvals

Amlodipine besylate and benazepril hydrochloride capsules

Product Name
氨氯地平贝那普利胶囊
Approval Number
国药准字H20253085
Approval Date
Jan 8, 2025
NMPA

Fluvoxamine Maleate Tablets

Product Name
马来酸氟伏沙明片
Approval Number
国药准字H20249005
Approval Date
Sep 26, 2024
NMPA

Acetylcysteine Granules

Product Name
乙酰半胱氨酸颗粒
Approval Number
国药准字H20243804
Approval Date
May 21, 2024
NMPA

Milnacipran Hydrochloride Tablets

Product Name
盐酸米那普仑片
Approval Number
国药准字H20243552
Approval Date
Apr 24, 2024
NMPA

Sildenafil Citrate Orodispersible Tablets

Product Name
枸橼酸西地那非口崩片
Approval Number
国药准字H20233877
Approval Date
Jun 30, 2023
NMPA

Vortioxetine Hydrobromide Tablets

Product Name
氢溴酸伏硫西汀片
Approval Number
国药准字H20233417
Approval Date
Apr 4, 2023
NMPA

Amisulpride Tablets

Product Name
氨磺必利片
Approval Number
国药准字H20203734
Approval Date
Dec 29, 2020
NMPA

Olanzapine Tablets

Product Name
奥氮平片
Approval Number
国药准字H20203472
Approval Date
Sep 8, 2020
NMPA

四神丸

Approval Number
国药准字Z13020851
Approval Date
Aug 28, 2020
NMPA

香砂养胃丸

Approval Number
国药准字Z13020852
Approval Date
Aug 28, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.